GPR55 and neoplasm: Recent data have demonstrated that GPR55 is expressed by different human tumor entities, and its activation by its ligand L-α-lysophosphatidylinositol (LPI) has tumor-promoting effects reflected by an increased tumor cell proliferation, migration, and invasion capacity [10,11,12].